- 全部删除
您的购物车当前为空
Dehydroabiethylamine (NSC-2955) 是肝脏 CYP2B 活性的诱导剂。 Dehydroabiethylamine 抑制丙酮酸脱氢酶激酶 (PDK) 和细胞内胆固醇转运,具有抗肿瘤活性。

Dehydroabiethylamine (NSC-2955) 是肝脏 CYP2B 活性的诱导剂。 Dehydroabiethylamine 抑制丙酮酸脱氢酶激酶 (PDK) 和细胞内胆固醇转运,具有抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 g | ¥ 148 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 99 | In stock |
Dehydroabiethylamine 相关产品
| 产品描述 | Dehydroabiethylamine (NSC-2955) is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity. |
| 别名 | 脱氢松香胺, NSC-2955, NSC2955, NSC 2955, Leelamine free base, Leelamine, Dehydroabietylamine |
| 分子量 | 285.47 |
| 分子式 | C20H31N |
| CAS No. | 1446-61-3 |
| Smiles | [H][C@@]12CCc3cc(ccc3[C@@]1(C)CCC[C@@]2(C)CN)C(C)C |
| 密度 | 0.963 g/cm3 |
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (87.57 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容